EP3775274C0 - Verfahren zum nachweis von somatischen genetischen anomalien, kombination von fangsonden und nachweiskit - Google Patents

Verfahren zum nachweis von somatischen genetischen anomalien, kombination von fangsonden und nachweiskit

Info

Publication number
EP3775274C0
EP3775274C0 EP19717477.4A EP19717477A EP3775274C0 EP 3775274 C0 EP3775274 C0 EP 3775274C0 EP 19717477 A EP19717477 A EP 19717477A EP 3775274 C0 EP3775274 C0 EP 3775274C0
Authority
EP
European Patent Office
Prior art keywords
combination
detection kit
capture probe
genetic anomalies
somatic genetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP19717477.4A
Other languages
English (en)
French (fr)
Other versions
EP3775274B1 (de
EP3775274A1 (de
Inventor
Romain Boidot
Frédérique Vegran
François Ghiringhelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Bourgogne
Original Assignee
Universite de Bourgogne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Bourgogne filed Critical Universite de Bourgogne
Publication of EP3775274A1 publication Critical patent/EP3775274A1/de
Application granted granted Critical
Publication of EP3775274B1 publication Critical patent/EP3775274B1/de
Publication of EP3775274C0 publication Critical patent/EP3775274C0/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP19717477.4A 2018-04-11 2019-04-11 Verfahren zum nachweis von somatischen genetischen anomalien, kombination von fangsonden und nachweiskit Active EP3775274B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18305440.2A EP3553182A1 (de) 2018-04-11 2018-04-11 Verfahren zum nachweis von somatischen genetischen anomalien, kombination von fangsonden und nachweiskit
PCT/EP2019/059274 WO2019197541A1 (en) 2018-04-11 2019-04-11 Detection method of somatic genetic anomalies, combination of capture probes and kit of detection

Publications (3)

Publication Number Publication Date
EP3775274A1 EP3775274A1 (de) 2021-02-17
EP3775274B1 EP3775274B1 (de) 2023-12-20
EP3775274C0 true EP3775274C0 (de) 2023-12-20

Family

ID=62046816

Family Applications (2)

Application Number Title Priority Date Filing Date
EP18305440.2A Withdrawn EP3553182A1 (de) 2018-04-11 2018-04-11 Verfahren zum nachweis von somatischen genetischen anomalien, kombination von fangsonden und nachweiskit
EP19717477.4A Active EP3775274B1 (de) 2018-04-11 2019-04-11 Verfahren zum nachweis von somatischen genetischen anomalien, kombination von fangsonden und nachweiskit

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP18305440.2A Withdrawn EP3553182A1 (de) 2018-04-11 2018-04-11 Verfahren zum nachweis von somatischen genetischen anomalien, kombination von fangsonden und nachweiskit

Country Status (3)

Country Link
EP (2) EP3553182A1 (de)
ES (1) ES2972684T3 (de)
WO (1) WO2019197541A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112708665B (zh) * 2019-10-25 2024-06-18 益善生物技术股份有限公司 用于肺癌多基因突变测序文库的构建方法与试剂盒
CN112226502A (zh) * 2020-10-10 2021-01-15 福建医科大学附属协和医院 一种认知障碍和运动障碍相关基因的捕获方法和试剂盒
CN113278611B (zh) * 2021-03-07 2022-11-25 华中科技大学同济医学院附属协和医院 捕获测序探针及其用途
CN114369650B (zh) * 2022-03-21 2022-06-17 深圳市仙湖植物园(深圳市园林研究中心) 捕获探针的设计方法、捕获探针及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US7223833B1 (en) 1991-05-24 2007-05-29 Isis Pharmaceuticals, Inc. Peptide nucleic acid conjugates
US5981179A (en) 1991-11-14 1999-11-09 Digene Diagnostics, Inc. Continuous amplification reaction
US5539083A (en) 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US5604097A (en) 1994-10-13 1997-02-18 Spectragen, Inc. Methods for sorting polynucleotides using oligonucleotide tags
US5750341A (en) 1995-04-17 1998-05-12 Lynx Therapeutics, Inc. DNA sequencing by parallel oligonucleotide extensions
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
EP0972081B1 (de) 1997-04-01 2007-06-13 Solexa Ltd. Verfahren zur vervielfältigung von nukleinsäure
EP2341057A3 (de) 1997-09-12 2011-11-23 Exiqon A/S Oligonukleotidanaloga
US6787308B2 (en) 1998-07-30 2004-09-07 Solexa Ltd. Arrayed biomolecules and their use in sequencing
AR021833A1 (es) 1998-09-30 2002-08-07 Applied Research Systems Metodos de amplificacion y secuenciacion de acido nucleico
US20020119448A1 (en) * 1999-06-23 2002-08-29 Joseph A. Sorge Methods of enriching for and identifying polymorphisms
US7244559B2 (en) 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
US7211390B2 (en) 1999-09-16 2007-05-01 454 Life Sciences Corporation Method of sequencing a nucleic acid
ES2391213T3 (es) 2000-03-01 2012-11-22 Epoch Biosciences, Inc. Oligonucle�tidos modificados para discriminaci�n de desapareamiento
CN101128601B (zh) 2003-01-29 2011-06-08 454生命科学公司 核酸扩增和测序的方法
EP2653861B1 (de) 2006-12-14 2014-08-13 Life Technologies Corporation Verfahren zur Nukleinsäure-Sequenzierung mittels großer FET-Arrays
EP2489072A4 (de) 2009-10-14 2014-05-28 Lockheed Corp Schutzabdeckung für leiterplatten
US7995334B2 (en) 2010-01-06 2011-08-09 Apple Inc. Printed circuit board
KR102759126B1 (ko) * 2010-12-30 2025-01-24 파운데이션 메디신 인코포레이티드 종양 샘플의 다유전자 분석의 최적화

Also Published As

Publication number Publication date
EP3775274B1 (de) 2023-12-20
ES2972684T3 (es) 2024-06-14
WO2019197541A1 (en) 2019-10-17
EP3553182A1 (de) 2019-10-16
EP3775274A1 (de) 2021-02-17

Similar Documents

Publication Publication Date Title
EP3919907C0 (de) Verfahren zum quantitativen nachweis von einzelmolekülen und nachweisverfahren
EP4078514A4 (de) Verfahren und system zum detektieren physikalischer merkmale von objekten
EP3542718A4 (de) Vorrichtung zum testen der lungenfunktion und verfahren dafür
EP3510171A4 (de) Zusammensetzungen und verfahren zum nachweis von nukleinsäuremutationen
EP3953374A4 (de) Zusammensetzungen und verfahren zur detektion von analyten mittels biolumineszenz
EP4073378A4 (de) Verfahren und gerät zum detektieren von gier-zu-wind-anomalien, sowie vorrichtung und speichermedium dafür
EP3951531A4 (de) Verfahren zur erkennung von anomalien und system zur erkennung von anomalien
EP4426863A4 (de) Zusammensetzungen und verfahren zum nachweis von ophthalngealkrebs
EP3482209C0 (de) Alpha-synuklein-nachweistest und verfahren zur diagnose von alpha-synukleinopathien
EP3775274C0 (de) Verfahren zum nachweis von somatischen genetischen anomalien, kombination von fangsonden und nachweiskit
EP3540409A4 (de) System zum nachweis von substanzen und verfahren zum nachweis von substanzen
EP3647950A4 (de) Verfahren und vorrichtung zur detektion von speicheranomalien
EP3876065C0 (de) Verfahren zum bestimmen eines pfades entlang eines objekts, system und verfahren zum automatischen inspizieren eines objekts
EP3472692A4 (de) System und verfahren zur detektion von störungen
EP3464647A4 (de) Verfahren zum nachweis von noroviren
DE112016002050A5 (de) Verfahren und vorrichtung zur erkennung und bewertung von fahrbahnreflexionen
EP3908657A4 (de) Verfahren zum nachweis von analyten und zusammensetzungen davon
EP3644233C0 (de) Lernverfahren, lernvorrichtung zum nachweis der objekthaftigkeit durch nachweis der oberen linien und unteren linien der nächstgelegenem hindernisse und testverfahren, dieselbe verwendende testvorrichtung
EP3415912A4 (de) Analytdetektionsverfahren und reagenziensatz zum nachweis von analyten
EP3210071C0 (de) Vorrichtung und verfahren zum bestimmen von optischen parametern
EP3832548C0 (de) Verfahren zum testen und testvorrichtung
EP3594663A4 (de) Chip zum nachweis von gewünschten substanzen, vorrichtung zum nachweis von gewünschten substanzen und verfahren zum nachweis von gewünschten substanzen
EP3489677A4 (de) Verfahren zum nachweis von allergenen
EP4025925C0 (de) Batteriesensoranordnung und verfahren zum ausgleichen von batterien
EP3722811A4 (de) Kit und verfahren zum quantitativen nachweis von hbsag

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201008

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20220613

111L Licence recorded

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Free format text: EXCLUSIVE LICENSE

Name of requester: SATT SAYENS, FR

Effective date: 20230327

111L Licence recorded

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Free format text: EXCLUSIVE LICENSE

Name of requester: CLINIHOLDING, FR

Effective date: 20230418

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Free format text: EXCLUSIVE LICENSE

Name of requester: SATT SAYENS, FR

Effective date: 20230327

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20230710

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

111L Licence recorded

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Free format text: EXCLUSIVE LICENSE

Name of requester: CLINIHOLDING, FR

Effective date: 20230418

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Free format text: EXCLUSIVE LICENSE

Name of requester: SATT SAYENS, FR

Effective date: 20230327

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602019043568

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

U01 Request for unitary effect filed

Effective date: 20240116

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI

Effective date: 20240125

U20 Renewal fee for the european patent with unitary effect paid

Year of fee payment: 6

Effective date: 20240201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240321

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240321

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240320

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2972684

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20240614

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240420

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240420

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602019043568

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220

26N No opposition filed

Effective date: 20240923

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240430

U20 Renewal fee for the european patent with unitary effect paid

Year of fee payment: 7

Effective date: 20250204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240411

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20250204

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20250516

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20190411

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20190411

U20 Renewal fee for the european patent with unitary effect paid

Year of fee payment: 8

Effective date: 20260203